Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (HyTe-2)
Hyperglycemia in Joint Replacement Recipients: Glucose Metabolism Disorders and Metabolic Syndrome in Osteoarthritis Patients Before and After Primary Hip and Knee Replacement
Sponsor: Coxa, Hospital for Joint Replacement
Terminated
Primary researcher not able to continue research at the moment.
A observational or N/A phase clinical study on Hip Replacement and Hypercholesterolemia, this trial is terminated or withdrawn. The trial is conducted by Coxa, Hospital for Joint Replacement and has accumulated 13 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Nov 2023 — Jul 2024 [monthly]
Terminated
Status: Suspended → Terminated
-
Dec 2021 — Nov 2023 [monthly]
Suspended
-
Jan 2021 — Dec 2021 [monthly]
Suspended
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Suspended
-
Apr 2019 — Nov 2020 [monthly]
Suspended
-
Aug 2018 — Apr 2019 [monthly]
Suspended
-
Jun 2018 — Aug 2018 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
-
Apr 2018 — May 2018 [monthly]
Suspended
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Suspended NA
Status: Active Not Recruiting → Suspended
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coxa, Hospital for Joint Replacement
- Tampere University
- Tampere University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .